PhiChem(SZ:300398)2024-05-14 11:47Financial Performance - The company's operating revenue for Q1 2024 was ¥668,475,317.50, representing a 12.51% increase compared to ¥594,157,918.54 in the same period last year[4] - Net profit attributable to shareholders decreased by 17.13% to ¥59,841,252.83 from ¥72,212,645.69 year-on-year[4] - Basic and diluted earnings per share fell by 21.43% to ¥0.11 from ¥0.14 in the same period last year[5] - Operating profit for Q1 2024 was ¥72,380,204.98, down 12.6% from ¥82,445,569.52 in Q1 2023[35] - The total comprehensive income for the period was ¥64,710,650.61, compared to ¥61,412,775.12 in the same period last year[36] - The company reported a tax expense of ¥5,844,053.55, down from ¥7,451,394.81 in Q1 2023[35] Cash Flow and Liquidity - The net cash flow from operating activities improved significantly, reaching ¥91,545,576.54, a 173.37% increase from the previous year's negative cash flow of ¥124,769,378.66[4] - The total cash and cash equivalents at the end of the period amounted to 977,157,818.45 CNY, slightly up from 976,492,329.69 CNY year-over-year[39] - Cash inflow from financing activities totaled 217,018,335.72 CNY, while cash outflow was 251,896,085.08 CNY, resulting in a net cash flow of -34,877,749.36 CNY[39] - The company experienced a foreign exchange impact of 4,043,319.60 CNY on cash and cash equivalents during the quarter[39] Assets and Liabilities - The total assets at the end of Q1 2024 were ¥6,501,984,080.69, a slight increase of 0.25% from ¥6,485,522,219.69 at the end of the previous year[5] - The company's total equity increased to ¥4,014,769,382.93, compared to ¥3,949,677,012.58 in the previous quarter[32] - The total current liabilities decreased to CNY 1,557,538,118.60 from CNY 1,609,903,708.82, a reduction of about 3.2%[31] - The total liabilities decreased to CNY 2,487,214,697.76 from CNY 2,535,845,207.11, indicating a reduction of approximately 1.9%[31] Shareholder Information - The total number of common shareholders at the end of the reporting period is 44,362[13] - The largest shareholder, Feikai Holdings Limited, holds 22.37% of the shares, equating to 118,237,504 shares[13] - The second-largest shareholder, Shanghai Semiconductor Equipment Materials Industry Investment Management Co., Ltd., holds 6.78% or 35,846,210 shares[13] - The total number of shares held by the top 10 shareholders accounts for 32.75% of the total share capital[13] Convertible Bonds - The company plans to issue convertible bonds totaling up to RMB 832 million to enhance capital strength and profitability[20] - The company has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds[20] - The bond issuance will consist of 8.25 million units, with a coupon rate starting at 0.30% in the first year and increasing to 2.00% by the sixth year[21] - The initial conversion price for the bonds is set at RMB 19.34 per share[21] - The company completed the first-year interest payment for the "Feikai Convertible Bonds" at a rate of 0.30%, amounting to 3.00 CNY per 10 bonds[23] - The conversion price of the "Feikai Convertible Bonds" was adjusted from 15.56 CNY to 15.49 CNY per share effective June 16, 2022[23] Regulatory Compliance and Changes - The company is undergoing rectification measures as per the regulatory requirements from the China Securities Regulatory Commission, impacting the financial reporting for Q1 2024[6] - The first quarter report has not been audited, which may affect the reliability of the financial data presented[40] - The company has not yet adopted the new accounting standards for the current year, as indicated in the report[40] Research and Development - Research and development expenses increased to ¥46,084,366.43, up 9.3% from ¥41,918,118.01 in Q1 2023[35]